Dementia diagnoses up in individuals with acute kidney injury
By
Haymarket Media
Sep 05, 2024
Developing AKI was associated with a significantly increased rate of subsequent dementia; the pattern was consistent across dementia types.
SGLT-2 inhibitors may cut dementia risk in patients with diabetes
By
Haymarket Media
Sep 03, 2024
The findings show a greater effect with longer treatment, compared with dipeptidyl peptidase-4 inhibitors.
Dementia diagnoses drop, but early-onset disease may be increasing among some
By
Kimberly Bonvissuto
Sep 03, 2024
Two separate studies looking at dementia rates found a drop in diagnoses over time due to higher education and decreased smoking levels but an increase in potential early-onset dementia in Native populations.
2 ways to celebrate National Assisted Living Week
By
Lois A. Bowers
Sep 09, 2024
It’s National Assisted Living Week, and McKnight’s Senior Living is celebrating with a panel discussion on Wednesday and a podcast on Thursday. Here’s what you’ll want to know about those events.
Business briefs, Sept. 9
By
Kathleen Steele Gaivin
Sep 09, 2024
Grace Management’s memory care training program recognized by Alzheimer’s Association curriculum review … Parasol Alliance chief Amber Bardon named Best & Brightest CEO … Help at Home expands Georgia...
Senior living leaders to discuss pressing topics Sept. 11 at free virtual event
By
Lois A. Bowers
Sep 06, 2024
Get insights into how other senior living providers are innovating and addressing challenges when a panel of industry leaders discusses important issues facing assisted living providers — as well as...
Outdoor nighttime light exposure linked to prevalence of Alzheimer’s disease
By
Haymarket Media
Sep 06, 2024
Nighttime light exposure was more strongly linked to AD prevalence than any other disease factor among those younger than 65 years.
Is Eli Lilly using ‘granfluencers’ to raise awareness of its Alzheimer’s med?
By
Marc Iskowitz
Sep 04, 2024
Here’s why older internet celebs — granfluencers — soon might be making rounds on the Alzheimer’s drug marketing scene.
Multiple sclerosis linked to lower risk for Alzheimer’s disease pathology
By
Haymarket Media
Aug 30, 2024
A lower rate of amyloid-β plasma biomarker positivity was seen in multiple sclerosis patients compared with non-MS controls.
Regional variation seen in Alzheimer’s and related dementia diagnosis
Aug 19, 2024
The ADRD-specific diagnosis intensity varies most for Black, Hispanic and youngest subgroups.